4.7 Review

Current epidemiological and clinical features of COVID-19; a global perspective from China

期刊

JOURNAL OF INFECTION
卷 81, 期 1, 页码 1-9

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.jinf.2020.04.011

关键词

COVID-19; SARS-CoV-2; 2019-nCoV; Epidemiology; Intervention

资金

  1. National Natural Science Foundation of China [81701144, 81670567]
  2. Zhejiang Provincial Natural Science Foundation of China [LED20H190 0 03]

向作者/读者索取更多资源

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and represents a potentially fatal disease of great global public health importance. As of March 26, 2020, the outbreak of COVID-19 has resulted in 462,801 confirmed cases and 20,839 deaths globally, which is more than those caused by SARS and Middle East respiratory syndrome (MERS) in 2003 and 2013, respectively. The epidemic has posed considerable challenges worldwide. Under a strict mechanism of massive prevention and control, China has seen a rapid decrease in new cases of coronavirus; however, the global situation remains serious. Additionally, the origin of COVID-19 has not been determined and no specific antiviral treatment or vaccine is currently available. Based on the published data, this review systematically discusses the etiology, epidemiology, clinical characteristics, and current intervention measures related to COVID-19 in the hope that it may provide a reference for future studies and aid in the prevention and control of the COVID-19 epidemic. (C) 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据